<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://bridgeslab.sph.umich.edu/protocols/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Nporitsa</id>
	<title>Bridges Lab Protocols - User contributions [en]</title>
	<link rel="self" type="application/atom+xml" href="https://bridgeslab.sph.umich.edu/protocols/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Nporitsa"/>
	<link rel="alternate" type="text/html" href="https://bridgeslab.sph.umich.edu/protocols/index.php/Special:Contributions/Nporitsa"/>
	<updated>2026-04-19T18:27:59Z</updated>
	<subtitle>User contributions</subtitle>
	<generator>MediaWiki 1.45.1</generator>
	<entry>
		<id>https://bridgeslab.sph.umich.edu/protocols/index.php?title=Differentiation_of_MEFs&amp;diff=822</id>
		<title>Differentiation of MEFs</title>
		<link rel="alternate" type="text/html" href="https://bridgeslab.sph.umich.edu/protocols/index.php?title=Differentiation_of_MEFs&amp;diff=822"/>
		<updated>2013-12-23T20:02:34Z</updated>

		<summary type="html">&lt;p&gt;Nporitsa: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;br /&gt;
==Protocol== &lt;br /&gt;
Adipogenic Differentiation of Mouse Embryonic Fibroblasts (MEFs)&lt;br /&gt;
==Strains== &lt;br /&gt;
Wild type (Tsc2 +/+) and Tsc2 -/- (p53−/−) MEFs &lt;br /&gt;
==Source== &lt;br /&gt;
DJ Kwiatkowski (Brigham and Women&#039;s Hospital, Boston, MA)&lt;br /&gt;
==Papers== &lt;br /&gt;
•	Kwiatkowski DJ, Zhang H, Bandura JL, Heiberger KM, Glogauer M, et al. (2002) A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in TSC1 null cells. Hum Mol Genet 11: 525–534. &lt;br /&gt;
•	Zhang H, Cicchetti G, Onda H, Koon HB, Asrican K, et al. (2003) Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR. J Clin Invest 112: 1223–1233.&lt;br /&gt;
&lt;br /&gt;
==Materials==&lt;br /&gt;
•	DMEM (4.5 g/L glucose + L-glutamine – sodium pyruvate; Invitrogen catalog # 11965-092)&lt;br /&gt;
•	FBS (we test several batches from several sources for differentiation and insulin stimulated glucose uptake then order large quantities of that particular lot. Currently we are using Sigma cat# F2442, lot# 072K8403. Aliquot and store in 50 mL tubes at -20)&lt;br /&gt;
•	NCS (currently we are using Biowhittaker Cambrex cat# 14-416F, lot# 01106776; aliquot in 50 mL tubes and store at -20)&lt;br /&gt;
•	Penicillin/Streptomycin (100X Invitrogen Cat# 100378-016)&lt;br /&gt;
•	Insulin (Sigma I-5523). Dissolve in 0.01N Hydrochloric acid (28.7μl/50ml) as a 1 mg/ml stock. Aliquot into 1.5 mL tubes and store at -20&lt;br /&gt;
•	Dexamethasone (Sigma D-1756). Dissolve in ethanol as a 2.5 mM stock (0.049g/50ml). Aliquot into 1.5 tubes and store at -20.&lt;br /&gt;
•	MIX (Sigma I-5879). Add 2.78g MIX and 0.98g KOH and bring up to 50 mL. Aliquot into 1.5 mL tubes and store at -20&lt;br /&gt;
•	Fibroblast Media (DMEM + 10% NCS + 1X PSG; Sterile filter into new bottle)&lt;br /&gt;
•	Adipocyte Media (DMEM + 10 % L1-FBS + 1X PSG; Sterile filter into new bottle)&lt;br /&gt;
•	DMI Media (Adipocyte Media + Insulin (1000X dilution), Dexamethasone (10 000X dilution) and MIX (500X dilution); Sterile filter into new bottle after additions&lt;br /&gt;
•	Insulin Media (Adipocyte Media + Insulin; Sterile filter into new bottle after adding insulin)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Induction of MEF differentiation==&lt;br /&gt;
# Seed MEFs at 100% confluence in 12-well plates and grow for 2 days (D0).&lt;br /&gt;
# On day 0 (D0) treat MEFs with differentiation-inducing media containing insulin (830 nM), dexamethasone (1 µM), and 3-isobutyl-1-methylxanthine (IBMX, 0.5 mM).&lt;br /&gt;
# At 48 hours, replace the media with the maintenance DMEM medium containing 10% FBS and insulin (830-nM), followed by a replenishment of the media every 2 days until the end of adipogenic differentiation (prior to cells lifting off). &#039;&#039;&#039;Note1:&#039;&#039;&#039; Cells should shrink after day 1, and then start to round up. By *day 3 cells should begin to accumulate lipid (the media should change color as well)&lt;br /&gt;
# Protein lysate and RNA extraction is taken at day 4 (D3).  &#039;&#039;&#039;Note2:&#039;&#039;&#039; In the 12-well plate, Tsc2-/- MEFs started to be detached from the plate on D3, and consequently lysates were taken at that point to ensure adequate sample collection.	&#039;&#039;&#039;Note3:&#039;&#039;&#039; A 6-well plate can also be used to increase surface area and protein/RNA content from each treatment. Seeding density of 90% followed by 2 days of growth prior to adipogenic differentiation may increase adherence and maintenance of Tsc2-/- MEFs.&lt;/div&gt;</summary>
		<author><name>Nporitsa</name></author>
	</entry>
	<entry>
		<id>https://bridgeslab.sph.umich.edu/protocols/index.php?title=Differentiation_of_MEFs&amp;diff=821</id>
		<title>Differentiation of MEFs</title>
		<link rel="alternate" type="text/html" href="https://bridgeslab.sph.umich.edu/protocols/index.php?title=Differentiation_of_MEFs&amp;diff=821"/>
		<updated>2013-12-23T20:02:21Z</updated>

		<summary type="html">&lt;p&gt;Nporitsa: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;br /&gt;
==Protocol== Adipogenic Differentiation of Mouse Embryonic Fibroblasts (MEFs)&lt;br /&gt;
==Strains== Wild type (Tsc2 +/+) and Tsc2 -/- (p53−/−) MEFs &lt;br /&gt;
==Source== DJ Kwiatkowski (Brigham and Women&#039;s Hospital, Boston, MA)&lt;br /&gt;
==Papers== &lt;br /&gt;
•	Kwiatkowski DJ, Zhang H, Bandura JL, Heiberger KM, Glogauer M, et al. (2002) A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in TSC1 null cells. Hum Mol Genet 11: 525–534. &lt;br /&gt;
•	Zhang H, Cicchetti G, Onda H, Koon HB, Asrican K, et al. (2003) Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR. J Clin Invest 112: 1223–1233.&lt;br /&gt;
&lt;br /&gt;
==Materials==&lt;br /&gt;
•	DMEM (4.5 g/L glucose + L-glutamine – sodium pyruvate; Invitrogen catalog # 11965-092)&lt;br /&gt;
•	FBS (we test several batches from several sources for differentiation and insulin stimulated glucose uptake then order large quantities of that particular lot. Currently we are using Sigma cat# F2442, lot# 072K8403. Aliquot and store in 50 mL tubes at -20)&lt;br /&gt;
•	NCS (currently we are using Biowhittaker Cambrex cat# 14-416F, lot# 01106776; aliquot in 50 mL tubes and store at -20)&lt;br /&gt;
•	Penicillin/Streptomycin (100X Invitrogen Cat# 100378-016)&lt;br /&gt;
•	Insulin (Sigma I-5523). Dissolve in 0.01N Hydrochloric acid (28.7μl/50ml) as a 1 mg/ml stock. Aliquot into 1.5 mL tubes and store at -20&lt;br /&gt;
•	Dexamethasone (Sigma D-1756). Dissolve in ethanol as a 2.5 mM stock (0.049g/50ml). Aliquot into 1.5 tubes and store at -20.&lt;br /&gt;
•	MIX (Sigma I-5879). Add 2.78g MIX and 0.98g KOH and bring up to 50 mL. Aliquot into 1.5 mL tubes and store at -20&lt;br /&gt;
•	Fibroblast Media (DMEM + 10% NCS + 1X PSG; Sterile filter into new bottle)&lt;br /&gt;
•	Adipocyte Media (DMEM + 10 % L1-FBS + 1X PSG; Sterile filter into new bottle)&lt;br /&gt;
•	DMI Media (Adipocyte Media + Insulin (1000X dilution), Dexamethasone (10 000X dilution) and MIX (500X dilution); Sterile filter into new bottle after additions&lt;br /&gt;
•	Insulin Media (Adipocyte Media + Insulin; Sterile filter into new bottle after adding insulin)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Induction of MEF differentiation==&lt;br /&gt;
# Seed MEFs at 100% confluence in 12-well plates and grow for 2 days (D0).&lt;br /&gt;
# On day 0 (D0) treat MEFs with differentiation-inducing media containing insulin (830 nM), dexamethasone (1 µM), and 3-isobutyl-1-methylxanthine (IBMX, 0.5 mM).&lt;br /&gt;
# At 48 hours, replace the media with the maintenance DMEM medium containing 10% FBS and insulin (830-nM), followed by a replenishment of the media every 2 days until the end of adipogenic differentiation (prior to cells lifting off). &#039;&#039;&#039;Note1:&#039;&#039;&#039; Cells should shrink after day 1, and then start to round up. By *day 3 cells should begin to accumulate lipid (the media should change color as well)&lt;br /&gt;
# Protein lysate and RNA extraction is taken at day 4 (D3).  &#039;&#039;&#039;Note2:&#039;&#039;&#039; In the 12-well plate, Tsc2-/- MEFs started to be detached from the plate on D3, and consequently lysates were taken at that point to ensure adequate sample collection.	&#039;&#039;&#039;Note3:&#039;&#039;&#039; A 6-well plate can also be used to increase surface area and protein/RNA content from each treatment. Seeding density of 90% followed by 2 days of growth prior to adipogenic differentiation may increase adherence and maintenance of Tsc2-/- MEFs.&lt;/div&gt;</summary>
		<author><name>Nporitsa</name></author>
	</entry>
	<entry>
		<id>https://bridgeslab.sph.umich.edu/protocols/index.php?title=Differentiation_of_MEFs&amp;diff=820</id>
		<title>Differentiation of MEFs</title>
		<link rel="alternate" type="text/html" href="https://bridgeslab.sph.umich.edu/protocols/index.php?title=Differentiation_of_MEFs&amp;diff=820"/>
		<updated>2013-12-23T20:02:05Z</updated>

		<summary type="html">&lt;p&gt;Nporitsa: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;br /&gt;
==Protocol==Adipogenic Differentiation of Mouse Embryonic Fibroblasts (MEFs)&lt;br /&gt;
==Strains==Wild type (Tsc2 +/+) and Tsc2 -/- (p53−/−) MEFs &lt;br /&gt;
==Source==DJ Kwiatkowski (Brigham and Women&#039;s Hospital, Boston, MA)&lt;br /&gt;
==Papers== &lt;br /&gt;
•	Kwiatkowski DJ, Zhang H, Bandura JL, Heiberger KM, Glogauer M, et al. (2002) A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in TSC1 null cells. Hum Mol Genet 11: 525–534. &lt;br /&gt;
•	Zhang H, Cicchetti G, Onda H, Koon HB, Asrican K, et al. (2003) Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR. J Clin Invest 112: 1223–1233.&lt;br /&gt;
&lt;br /&gt;
==Materials==&lt;br /&gt;
•	DMEM (4.5 g/L glucose + L-glutamine – sodium pyruvate; Invitrogen catalog # 11965-092)&lt;br /&gt;
•	FBS (we test several batches from several sources for differentiation and insulin stimulated glucose uptake then order large quantities of that particular lot. Currently we are using Sigma cat# F2442, lot# 072K8403. Aliquot and store in 50 mL tubes at -20)&lt;br /&gt;
•	NCS (currently we are using Biowhittaker Cambrex cat# 14-416F, lot# 01106776; aliquot in 50 mL tubes and store at -20)&lt;br /&gt;
•	Penicillin/Streptomycin (100X Invitrogen Cat# 100378-016)&lt;br /&gt;
•	Insulin (Sigma I-5523). Dissolve in 0.01N Hydrochloric acid (28.7μl/50ml) as a 1 mg/ml stock. Aliquot into 1.5 mL tubes and store at -20&lt;br /&gt;
•	Dexamethasone (Sigma D-1756). Dissolve in ethanol as a 2.5 mM stock (0.049g/50ml). Aliquot into 1.5 tubes and store at -20.&lt;br /&gt;
•	MIX (Sigma I-5879). Add 2.78g MIX and 0.98g KOH and bring up to 50 mL. Aliquot into 1.5 mL tubes and store at -20&lt;br /&gt;
•	Fibroblast Media (DMEM + 10% NCS + 1X PSG; Sterile filter into new bottle)&lt;br /&gt;
•	Adipocyte Media (DMEM + 10 % L1-FBS + 1X PSG; Sterile filter into new bottle)&lt;br /&gt;
•	DMI Media (Adipocyte Media + Insulin (1000X dilution), Dexamethasone (10 000X dilution) and MIX (500X dilution); Sterile filter into new bottle after additions&lt;br /&gt;
•	Insulin Media (Adipocyte Media + Insulin; Sterile filter into new bottle after adding insulin)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Induction of MEF differentiation==&lt;br /&gt;
# Seed MEFs at 100% confluence in 12-well plates and grow for 2 days (D0).&lt;br /&gt;
# On day 0 (D0) treat MEFs with differentiation-inducing media containing insulin (830 nM), dexamethasone (1 µM), and 3-isobutyl-1-methylxanthine (IBMX, 0.5 mM).&lt;br /&gt;
# At 48 hours, replace the media with the maintenance DMEM medium containing 10% FBS and insulin (830-nM), followed by a replenishment of the media every 2 days until the end of adipogenic differentiation (prior to cells lifting off). &#039;&#039;&#039;Note1:&#039;&#039;&#039; Cells should shrink after day 1, and then start to round up. By *day 3 cells should begin to accumulate lipid (the media should change color as well)&lt;br /&gt;
# Protein lysate and RNA extraction is taken at day 4 (D3).  &#039;&#039;&#039;Note2:&#039;&#039;&#039; In the 12-well plate, Tsc2-/- MEFs started to be detached from the plate on D3, and consequently lysates were taken at that point to ensure adequate sample collection.	&#039;&#039;&#039;Note3:&#039;&#039;&#039; A 6-well plate can also be used to increase surface area and protein/RNA content from each treatment. Seeding density of 90% followed by 2 days of growth prior to adipogenic differentiation may increase adherence and maintenance of Tsc2-/- MEFs.&lt;/div&gt;</summary>
		<author><name>Nporitsa</name></author>
	</entry>
	<entry>
		<id>https://bridgeslab.sph.umich.edu/protocols/index.php?title=Differentiation_of_MEFs&amp;diff=819</id>
		<title>Differentiation of MEFs</title>
		<link rel="alternate" type="text/html" href="https://bridgeslab.sph.umich.edu/protocols/index.php?title=Differentiation_of_MEFs&amp;diff=819"/>
		<updated>2013-12-23T20:01:42Z</updated>

		<summary type="html">&lt;p&gt;Nporitsa: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;br /&gt;
&#039;&#039;&#039;==Protocol==&#039;&#039;&#039;Adipogenic Differentiation of Mouse Embryonic Fibroblasts (MEFs)&lt;br /&gt;
&#039;&#039;&#039;==Strains==&#039;&#039;&#039; Wild type (Tsc2 +/+) and Tsc2 -/- (p53−/−) MEFs &lt;br /&gt;
&#039;&#039;&#039;==Source==&#039;&#039;&#039; DJ Kwiatkowski (Brigham and Women&#039;s Hospital, Boston, MA)&lt;br /&gt;
==Papers== &lt;br /&gt;
•	Kwiatkowski DJ, Zhang H, Bandura JL, Heiberger KM, Glogauer M, et al. (2002) A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in TSC1 null cells. Hum Mol Genet 11: 525–534. &lt;br /&gt;
•	Zhang H, Cicchetti G, Onda H, Koon HB, Asrican K, et al. (2003) Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR. J Clin Invest 112: 1223–1233.&lt;br /&gt;
&lt;br /&gt;
==Materials==&lt;br /&gt;
•	DMEM (4.5 g/L glucose + L-glutamine – sodium pyruvate; Invitrogen catalog # 11965-092)&lt;br /&gt;
•	FBS (we test several batches from several sources for differentiation and insulin stimulated glucose uptake then order large quantities of that particular lot. Currently we are using Sigma cat# F2442, lot# 072K8403. Aliquot and store in 50 mL tubes at -20)&lt;br /&gt;
•	NCS (currently we are using Biowhittaker Cambrex cat# 14-416F, lot# 01106776; aliquot in 50 mL tubes and store at -20)&lt;br /&gt;
•	Penicillin/Streptomycin (100X Invitrogen Cat# 100378-016)&lt;br /&gt;
•	Insulin (Sigma I-5523). Dissolve in 0.01N Hydrochloric acid (28.7μl/50ml) as a 1 mg/ml stock. Aliquot into 1.5 mL tubes and store at -20&lt;br /&gt;
•	Dexamethasone (Sigma D-1756). Dissolve in ethanol as a 2.5 mM stock (0.049g/50ml). Aliquot into 1.5 tubes and store at -20.&lt;br /&gt;
•	MIX (Sigma I-5879). Add 2.78g MIX and 0.98g KOH and bring up to 50 mL. Aliquot into 1.5 mL tubes and store at -20&lt;br /&gt;
•	Fibroblast Media (DMEM + 10% NCS + 1X PSG; Sterile filter into new bottle)&lt;br /&gt;
•	Adipocyte Media (DMEM + 10 % L1-FBS + 1X PSG; Sterile filter into new bottle)&lt;br /&gt;
•	DMI Media (Adipocyte Media + Insulin (1000X dilution), Dexamethasone (10 000X dilution) and MIX (500X dilution); Sterile filter into new bottle after additions&lt;br /&gt;
•	Insulin Media (Adipocyte Media + Insulin; Sterile filter into new bottle after adding insulin)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Induction of MEF differentiation==&lt;br /&gt;
# Seed MEFs at 100% confluence in 12-well plates and grow for 2 days (D0).&lt;br /&gt;
# On day 0 (D0) treat MEFs with differentiation-inducing media containing insulin (830 nM), dexamethasone (1 µM), and 3-isobutyl-1-methylxanthine (IBMX, 0.5 mM).&lt;br /&gt;
# At 48 hours, replace the media with the maintenance DMEM medium containing 10% FBS and insulin (830-nM), followed by a replenishment of the media every 2 days until the end of adipogenic differentiation (prior to cells lifting off). &#039;&#039;&#039;Note1:&#039;&#039;&#039; Cells should shrink after day 1, and then start to round up. By *day 3 cells should begin to accumulate lipid (the media should change color as well)&lt;br /&gt;
# Protein lysate and RNA extraction is taken at day 4 (D3).  &#039;&#039;&#039;Note2:&#039;&#039;&#039; In the 12-well plate, Tsc2-/- MEFs started to be detached from the plate on D3, and consequently lysates were taken at that point to ensure adequate sample collection.	&#039;&#039;&#039;Note3:&#039;&#039;&#039; A 6-well plate can also be used to increase surface area and protein/RNA content from each treatment. Seeding density of 90% followed by 2 days of growth prior to adipogenic differentiation may increase adherence and maintenance of Tsc2-/- MEFs.&lt;/div&gt;</summary>
		<author><name>Nporitsa</name></author>
	</entry>
	<entry>
		<id>https://bridgeslab.sph.umich.edu/protocols/index.php?title=Differentiation_of_MEFs&amp;diff=818</id>
		<title>Differentiation of MEFs</title>
		<link rel="alternate" type="text/html" href="https://bridgeslab.sph.umich.edu/protocols/index.php?title=Differentiation_of_MEFs&amp;diff=818"/>
		<updated>2013-12-23T20:01:18Z</updated>

		<summary type="html">&lt;p&gt;Nporitsa: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;br /&gt;
&#039;&#039;&#039;==Protocol==&#039;&#039;&#039;Adipogenic Differentiation of Mouse Embryonic Fibroblasts (MEFs)&lt;br /&gt;
&#039;&#039;&#039;==Strains==&#039;&#039;&#039; Wild type (Tsc2 +/+) and Tsc2 -/- (p53−/−) MEFs &lt;br /&gt;
&#039;&#039;&#039;==Source==&#039;&#039;&#039; DJ Kwiatkowski (Brigham and Women&#039;s Hospital, Boston, MA)&lt;br /&gt;
&#039;&#039;&#039;==Papers==&#039;&#039;&#039; &lt;br /&gt;
•	Kwiatkowski DJ, Zhang H, Bandura JL, Heiberger KM, Glogauer M, et al. (2002) A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in TSC1 null cells. Hum Mol Genet 11: 525–534. &lt;br /&gt;
•	Zhang H, Cicchetti G, Onda H, Koon HB, Asrican K, et al. (2003) Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR. J Clin Invest 112: 1223–1233.&lt;br /&gt;
&lt;br /&gt;
==Materials==&lt;br /&gt;
•	DMEM (4.5 g/L glucose + L-glutamine – sodium pyruvate; Invitrogen catalog # 11965-092)&lt;br /&gt;
•	FBS (we test several batches from several sources for differentiation and insulin stimulated glucose uptake then order large quantities of that particular lot. Currently we are using Sigma cat# F2442, lot# 072K8403. Aliquot and store in 50 mL tubes at -20)&lt;br /&gt;
•	NCS (currently we are using Biowhittaker Cambrex cat# 14-416F, lot# 01106776; aliquot in 50 mL tubes and store at -20)&lt;br /&gt;
•	Penicillin/Streptomycin (100X Invitrogen Cat# 100378-016)&lt;br /&gt;
•	Insulin (Sigma I-5523). Dissolve in 0.01N Hydrochloric acid (28.7μl/50ml) as a 1 mg/ml stock. Aliquot into 1.5 mL tubes and store at -20&lt;br /&gt;
•	Dexamethasone (Sigma D-1756). Dissolve in ethanol as a 2.5 mM stock (0.049g/50ml). Aliquot into 1.5 tubes and store at -20.&lt;br /&gt;
•	MIX (Sigma I-5879). Add 2.78g MIX and 0.98g KOH and bring up to 50 mL. Aliquot into 1.5 mL tubes and store at -20&lt;br /&gt;
•	Fibroblast Media (DMEM + 10% NCS + 1X PSG; Sterile filter into new bottle)&lt;br /&gt;
•	Adipocyte Media (DMEM + 10 % L1-FBS + 1X PSG; Sterile filter into new bottle)&lt;br /&gt;
•	DMI Media (Adipocyte Media + Insulin (1000X dilution), Dexamethasone (10 000X dilution) and MIX (500X dilution); Sterile filter into new bottle after additions&lt;br /&gt;
•	Insulin Media (Adipocyte Media + Insulin; Sterile filter into new bottle after adding insulin)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Induction of MEF differentiation==&lt;br /&gt;
# Seed MEFs at 100% confluence in 12-well plates and grow for 2 days (D0).&lt;br /&gt;
# On day 0 (D0) treat MEFs with differentiation-inducing media containing insulin (830 nM), dexamethasone (1 µM), and 3-isobutyl-1-methylxanthine (IBMX, 0.5 mM).&lt;br /&gt;
# At 48 hours, replace the media with the maintenance DMEM medium containing 10% FBS and insulin (830-nM), followed by a replenishment of the media every 2 days until the end of adipogenic differentiation (prior to cells lifting off). &#039;&#039;&#039;Note1:&#039;&#039;&#039; Cells should shrink after day 1, and then start to round up. By *day 3 cells should begin to accumulate lipid (the media should change color as well)&lt;br /&gt;
# Protein lysate and RNA extraction is taken at day 4 (D3).  &#039;&#039;&#039;Note2:&#039;&#039;&#039; In the 12-well plate, Tsc2-/- MEFs started to be detached from the plate on D3, and consequently lysates were taken at that point to ensure adequate sample collection.	&#039;&#039;&#039;Note3:&#039;&#039;&#039; A 6-well plate can also be used to increase surface area and protein/RNA content from each treatment. Seeding density of 90% followed by 2 days of growth prior to adipogenic differentiation may increase adherence and maintenance of Tsc2-/- MEFs.&lt;/div&gt;</summary>
		<author><name>Nporitsa</name></author>
	</entry>
	<entry>
		<id>https://bridgeslab.sph.umich.edu/protocols/index.php?title=Differentiation_of_MEFs&amp;diff=817</id>
		<title>Differentiation of MEFs</title>
		<link rel="alternate" type="text/html" href="https://bridgeslab.sph.umich.edu/protocols/index.php?title=Differentiation_of_MEFs&amp;diff=817"/>
		<updated>2013-12-23T19:58:50Z</updated>

		<summary type="html">&lt;p&gt;Nporitsa: /* Induction of MEF differentiation */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;br /&gt;
Protocol: Adipogenic Differentiation of Mouse Embryonic Fibroblasts (MEFs)&lt;br /&gt;
Strains: Wild type (Tsc2 +/+) and Tsc2 -/- (p53−/−) MEFs &lt;br /&gt;
Source: DJ Kwiatkowski (Brigham and Women&#039;s Hospital, Boston, MA)&lt;br /&gt;
Papers: &lt;br /&gt;
•	Kwiatkowski DJ, Zhang H, Bandura JL, Heiberger KM, Glogauer M, et al. (2002) A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in TSC1 null cells. Hum Mol Genet 11: 525–534. &lt;br /&gt;
•	Zhang H, Cicchetti G, Onda H, Koon HB, Asrican K, et al. (2003) Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR. J Clin Invest 112: 1223–1233.&lt;br /&gt;
&lt;br /&gt;
Materials&lt;br /&gt;
•	DMEM (4.5 g/L glucose + L-glutamine – sodium pyruvate; Invitrogen catalog # 11965-092)&lt;br /&gt;
•	FBS (we test several batches from several sources for differentiation and insulin stimulated glucose uptake then order large quantities of that particular lot. Currently we are using Sigma cat# F2442, lot# 072K8403. Aliquot and store in 50 mL tubes at -20)&lt;br /&gt;
•	NCS (currently we are using Biowhittaker Cambrex cat# 14-416F, lot# 01106776; aliquot in 50 mL tubes and store at -20)&lt;br /&gt;
•	Penicillin/Streptomycin (100X Invitrogen Cat# 100378-016)&lt;br /&gt;
•	Insulin (Sigma I-5523). Dissolve in 0.01N Hydrochloric acid (28.7μl/50ml) as a 1 mg/ml stock. Aliquot into 1.5 mL tubes and store at -20&lt;br /&gt;
•	Dexamethasone (Sigma D-1756). Dissolve in ethanol as a 2.5 mM stock (0.049g/50ml). Aliquot into 1.5 tubes and store at -20.&lt;br /&gt;
•	MIX (Sigma I-5879). Add 2.78g MIX and 0.98g KOH and bring up to 50 mL. Aliquot into 1.5 mL tubes and store at -20&lt;br /&gt;
•	Fibroblast Media (DMEM + 10% NCS + 1X PSG; Sterile filter into new bottle)&lt;br /&gt;
•	Adipocyte Media (DMEM + 10 % L1-FBS + 1X PSG; Sterile filter into new bottle)&lt;br /&gt;
•	DMI Media (Adipocyte Media + Insulin (1000X dilution), Dexamethasone (10 000X dilution) and MIX (500X dilution); Sterile filter into new bottle after additions&lt;br /&gt;
•	Insulin Media (Adipocyte Media + Insulin; Sterile filter into new bottle after adding insulin)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Induction of MEF differentiation==&lt;br /&gt;
# Seed MEFs at 100% confluence in 12-well plates and grow for 2 days (D0).&lt;br /&gt;
# On day 0 (D0) treat MEFs with differentiation-inducing media containing insulin (830 nM), dexamethasone (1 µM), and 3-isobutyl-1-methylxanthine (IBMX, 0.5 mM).&lt;br /&gt;
# At 48 hours, replace the media with the maintenance DMEM medium containing 10% FBS and insulin (830-nM), followed by a replenishment of the media every 2 days until the end of adipogenic differentiation (prior to cells lifting off). &#039;&#039;&#039;Note1:&#039;&#039;&#039; Cells should shrink after day 1, and then start to round up. By *day 3 cells should begin to accumulate lipid (the media should change color as well)&lt;br /&gt;
# Protein lysate and RNA extraction is taken at day 4 (D3).  &#039;&#039;&#039;Note2:&#039;&#039;&#039; In the 12-well plate, Tsc2-/- MEFs started to be detached from the plate on D3, and consequently lysates were taken at that point to ensure adequate sample collection.	&#039;&#039;&#039;Note3:&#039;&#039;&#039; A 6-well plate can also be used to increase surface area and protein/RNA content from each treatment. Seeding density of 90% followed by 2 days of growth prior to adipogenic differentiation may increase adherence and maintenance of Tsc2-/- MEFs.&lt;/div&gt;</summary>
		<author><name>Nporitsa</name></author>
	</entry>
	<entry>
		<id>https://bridgeslab.sph.umich.edu/protocols/index.php?title=Differentiation_of_MEFs&amp;diff=816</id>
		<title>Differentiation of MEFs</title>
		<link rel="alternate" type="text/html" href="https://bridgeslab.sph.umich.edu/protocols/index.php?title=Differentiation_of_MEFs&amp;diff=816"/>
		<updated>2013-12-23T19:54:18Z</updated>

		<summary type="html">&lt;p&gt;Nporitsa: Created new page&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;br /&gt;
Protocol: Adipogenic Differentiation of Mouse Embryonic Fibroblasts (MEFs)&lt;br /&gt;
Strains: Wild type (Tsc2 +/+) and Tsc2 -/- (p53−/−) MEFs &lt;br /&gt;
Source: DJ Kwiatkowski (Brigham and Women&#039;s Hospital, Boston, MA)&lt;br /&gt;
Papers: &lt;br /&gt;
•	Kwiatkowski DJ, Zhang H, Bandura JL, Heiberger KM, Glogauer M, et al. (2002) A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in TSC1 null cells. Hum Mol Genet 11: 525–534. &lt;br /&gt;
•	Zhang H, Cicchetti G, Onda H, Koon HB, Asrican K, et al. (2003) Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR. J Clin Invest 112: 1223–1233.&lt;br /&gt;
&lt;br /&gt;
Materials&lt;br /&gt;
•	DMEM (4.5 g/L glucose + L-glutamine – sodium pyruvate; Invitrogen catalog # 11965-092)&lt;br /&gt;
•	FBS (we test several batches from several sources for differentiation and insulin stimulated glucose uptake then order large quantities of that particular lot. Currently we are using Sigma cat# F2442, lot# 072K8403. Aliquot and store in 50 mL tubes at -20)&lt;br /&gt;
•	NCS (currently we are using Biowhittaker Cambrex cat# 14-416F, lot# 01106776; aliquot in 50 mL tubes and store at -20)&lt;br /&gt;
•	Penicillin/Streptomycin (100X Invitrogen Cat# 100378-016)&lt;br /&gt;
•	Insulin (Sigma I-5523). Dissolve in 0.01N Hydrochloric acid (28.7μl/50ml) as a 1 mg/ml stock. Aliquot into 1.5 mL tubes and store at -20&lt;br /&gt;
•	Dexamethasone (Sigma D-1756). Dissolve in ethanol as a 2.5 mM stock (0.049g/50ml). Aliquot into 1.5 tubes and store at -20.&lt;br /&gt;
•	MIX (Sigma I-5879). Add 2.78g MIX and 0.98g KOH and bring up to 50 mL. Aliquot into 1.5 mL tubes and store at -20&lt;br /&gt;
•	Fibroblast Media (DMEM + 10% NCS + 1X PSG; Sterile filter into new bottle)&lt;br /&gt;
•	Adipocyte Media (DMEM + 10 % L1-FBS + 1X PSG; Sterile filter into new bottle)&lt;br /&gt;
•	DMI Media (Adipocyte Media + Insulin (1000X dilution), Dexamethasone (10 000X dilution) and MIX (500X dilution); Sterile filter into new bottle after additions&lt;br /&gt;
•	Insulin Media (Adipocyte Media + Insulin; Sterile filter into new bottle after adding insulin)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Induction of MEF differentiation==&lt;br /&gt;
# Seed MEFs at 100% confluence in 12-well plates and grow for 2 days (D0).&lt;br /&gt;
# On day 0 (D0) treat MEFs with differentiation-inducing media containing insulin (830 nM), dexamethasone (1 µM), and 3-isobutyl-1-methylxanthine (IBMX, 0.5 mM).&lt;br /&gt;
3.	At 48 hours, replace the media with the maintenance DMEM medium containing 10% FBS and insulin (830-nM), followed by a replenishment of the media every 2 days until the end of adipogenic differentiation (prior to cells lifting off).&lt;br /&gt;
•	Note1 Cells should shrink after day 1, and then start to round up. By *day 3 cells should begin to accumulate lipid (the media should change color as well)&lt;br /&gt;
4.	Protein lysate and RNA extraction is taken at day 4 (D3).  &lt;br /&gt;
•	Note2: In the 12-well plate, Tsc2-/- MEFs started to be detached from the plate on D3, and consequently lysates were taken at that point to ensure adequate sample collection.&lt;br /&gt;
•	Note3: A 6-well plate can also be used to increase surface area and protein/RNA content from each treatment. Seeding density of 90% followed by 2 days of growth prior to adipogenic differentiation may increase adherence and maintenance of Tsc2-/- MEFs.&lt;/div&gt;</summary>
		<author><name>Nporitsa</name></author>
	</entry>
	<entry>
		<id>https://bridgeslab.sph.umich.edu/protocols/index.php?title=Wiki_new_protocols&amp;diff=815</id>
		<title>Wiki new protocols</title>
		<link rel="alternate" type="text/html" href="https://bridgeslab.sph.umich.edu/protocols/index.php?title=Wiki_new_protocols&amp;diff=815"/>
		<updated>2013-12-23T19:41:25Z</updated>

		<summary type="html">&lt;p&gt;Nporitsa: Replaced content with &amp;quot;\&amp;quot;&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;\&lt;/div&gt;</summary>
		<author><name>Nporitsa</name></author>
	</entry>
	<entry>
		<id>https://bridgeslab.sph.umich.edu/protocols/index.php?title=Wiki_new_protocols&amp;diff=814</id>
		<title>Wiki new protocols</title>
		<link rel="alternate" type="text/html" href="https://bridgeslab.sph.umich.edu/protocols/index.php?title=Wiki_new_protocols&amp;diff=814"/>
		<updated>2013-12-23T19:37:22Z</updated>

		<summary type="html">&lt;p&gt;Nporitsa: Differentiation of Tsc2 MEFs&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;br /&gt;
Protocol: Adipogenic Differentiation of Mouse Embryonic Fibroblasts (MEFs)&lt;br /&gt;
Strains: Wild type (Tsc2 +/+) and Tsc2 -/- (p53−/−) MEFs &lt;br /&gt;
Source: DJ Kwiatkowski (Brigham and Women&#039;s Hospital, Boston, MA)&lt;br /&gt;
Papers: &lt;br /&gt;
•	Kwiatkowski DJ, Zhang H, Bandura JL, Heiberger KM, Glogauer M, et al. (2002) A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in TSC1 null cells. Hum Mol Genet 11: 525–534. &lt;br /&gt;
•	Zhang H, Cicchetti G, Onda H, Koon HB, Asrican K, et al. (2003) Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR. J Clin Invest 112: 1223–1233.&lt;br /&gt;
&lt;br /&gt;
Materials&lt;br /&gt;
•	DMEM (4.5 g/L glucose + L-glutamine – sodium pyruvate; Invitrogen catalog # 11965-092)&lt;br /&gt;
•	FBS (we test several batches from several sources for differentiation and insulin stimulated glucose uptake then order large quantities of that particular lot. Currently we are using Sigma cat# F2442, lot# 072K8403. Aliquot and store in 50 mL tubes at -20)&lt;br /&gt;
•	NCS (currently we are using Biowhittaker Cambrex cat# 14-416F, lot# 01106776; aliquot in 50 mL tubes and store at -20)&lt;br /&gt;
•	Penicillin/Streptomycin (100X Invitrogen Cat# 100378-016)&lt;br /&gt;
•	Insulin (Sigma I-5523). Dissolve in 0.01N Hydrochloric acid (28.7μl/50ml) as a 1 mg/ml stock. Aliquot into 1.5 mL tubes and store at -20&lt;br /&gt;
•	Dexamethasone (Sigma D-1756). Dissolve in ethanol as a 2.5 mM stock (0.049g/50ml). Aliquot into 1.5 tubes and store at -20.&lt;br /&gt;
•	MIX (Sigma I-5879). Add 2.78g MIX and 0.98g KOH and bring up to 50 mL. Aliquot into 1.5 mL tubes and store at -20&lt;br /&gt;
•	Fibroblast Media (DMEM + 10% NCS + 1X PSG; Sterile filter into new bottle)&lt;br /&gt;
•	Adipocyte Media (DMEM + 10 % L1-FBS + 1X PSG; Sterile filter into new bottle)&lt;br /&gt;
•	DMI Media (Adipocyte Media + Insulin (1000X dilution), Dexamethasone (10 000X dilution) and MIX (500X dilution); Sterile filter into new bottle after additions&lt;br /&gt;
•	Insulin Media (Adipocyte Media + Insulin; Sterile filter into new bottle after adding insulin)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Induction of MEF differentiation: &lt;br /&gt;
1.	Seed MEFs at 100% confluence in 12-well plates and grow for 2 days (D0).&lt;br /&gt;
2.	On day 0 (D0) treat MEFs with differentiation-inducing media containing insulin (830 nM), dexamethasone (1 µM), and 3-isobutyl-1-methylxanthine (IBMX, 0.5 mM).&lt;br /&gt;
3.	At 48 hours, replace the media with the maintenance DMEM medium containing 10% FBS and insulin (830-nM), followed by a replenishment of the media every 2 days until the end of adipogenic differentiation (prior to cells lifting off).&lt;br /&gt;
•	Note1 Cells should shrink after day 1, and then start to round up. By *day 3 cells should begin to accumulate lipid (the media should change color as well)&lt;br /&gt;
4.	Protein lysate and RNA extraction is taken at day 4 (D3).  &lt;br /&gt;
•	Note2: In the 12-well plate, Tsc2-/- MEFs started to be detached from the plate on D3, and consequently lysates were taken at that point to ensure adequate sample collection.&lt;br /&gt;
•	Note3: A 6-well plate can also be used to increase surface area and protein/RNA content from each treatment. Seeding density of 90% followed by 2 days of growth prior to adipogenic differentiation may increase adherence and maintenance of Tsc2-/- MEFs.&lt;/div&gt;</summary>
		<author><name>Nporitsa</name></author>
	</entry>
	<entry>
		<id>https://bridgeslab.sph.umich.edu/protocols/index.php?title=Differentiation_of_3T3-L1_Cells&amp;diff=813</id>
		<title>Differentiation of 3T3-L1 Cells</title>
		<link rel="alternate" type="text/html" href="https://bridgeslab.sph.umich.edu/protocols/index.php?title=Differentiation_of_3T3-L1_Cells&amp;diff=813"/>
		<updated>2013-12-23T19:34:37Z</updated>

		<summary type="html">&lt;p&gt;Nporitsa: /* Reference */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
&lt;br /&gt;
==Materials==&lt;br /&gt;
*&#039;&#039;&#039;DMEM&#039;&#039;&#039; (4.5 g/L glucose + L-glutamine – sodium pyruvate; Invitrogen catalog #  11965-092)&lt;br /&gt;
*&#039;&#039;&#039;FBS&#039;&#039;&#039; (we test several batches from several sources for differentiation and insulin stimulated glucose uptake then order large quantities of that particular lot.  Currently we are using Sigma cat# F2442, lot# 072K8403.  Aliquot and store in 50 mL tubes at -20)&lt;br /&gt;
*&#039;&#039;&#039;NCS&#039;&#039;&#039; (currently we are using Biowhittaker Cambrex cat# 14-416F, lot# 01106776; aliquot in 50 mL tubes and store at -20)&lt;br /&gt;
*&#039;&#039;&#039;PSG&#039;&#039;&#039; (100X Invitrogen Cat# 100378-016)&lt;br /&gt;
*&#039;&#039;&#039;Insulin&#039;&#039;&#039; (Sigma I-5523).  Dissolve in 0.01N Hydrochloric acid (28.7μl/50ml) as a 1 mg/ml stock.  Aliquot into 1.5 mL tubes and store at -20&lt;br /&gt;
*&#039;&#039;&#039;Dexamethasone&#039;&#039;&#039; (Sigma D-1756).  Dissolve in ethanol as a 2.5 mM stock (0.049g/50ml).  Aliquot into 1.5 tubes and store at -20.&lt;br /&gt;
*&#039;&#039;&#039;MIX&#039;&#039;&#039; (Sigma I-5879).  Add 2.78g MIX and 0.98g KOH and bring up to 50 mL.   Aliquot into 1.5 mL tubes and store at -20&lt;br /&gt;
*&#039;&#039;&#039;Fibroblast Media&#039;&#039;&#039; (DMEM + 10% NCS + 1X PSG; Sterile filter into new bottle)&lt;br /&gt;
*&#039;&#039;&#039;Adipocyte Media&#039;&#039;&#039; (DMEM + 10 % L1-FBS + 1X PSG; Sterile filter into new bottle)&lt;br /&gt;
*&#039;&#039;&#039;DMI Media&#039;&#039;&#039; (Adipocyte Media + Insulin (1000X dilution), Dexamethasone (10 000X dilution) and MIX (500X dilution); Sterile filter into new bottle after additions&lt;br /&gt;
*&#039;&#039;&#039;Insulin Media&#039;&#039;&#039; (Adipocyte Media + Insulin (1000X dilution); Sterile filter into new bottle after adding insulin)&lt;br /&gt;
&lt;br /&gt;
[[File:3T3-L1_Adipocyte_Differentiation_Schematic.png]]&lt;br /&gt;
&lt;br /&gt;
==Fibroblast Culture==&lt;br /&gt;
*Cells can be grown at 37C + 8% CO2,  and split 10-20X.  Typically healthy fibroblasts will repopulate in 2-3 days after a 10X dilution.&lt;br /&gt;
*Split cells when at about 80% confluence.  Confluence initiates the differentiation program, so if cells reach confluence, you will need to thaw another DMSO stock and start over.  Splitting cells will normally not reverse this&lt;br /&gt;
*When splitting cells, wash cells 2x with sterile PBS (-/-) then add 0.05% trypsin and sit at room temperature for 2-5 min.  Be careful not to over-trypsinize cells&lt;br /&gt;
*Cells can normally be passaged up to about passage # 25 without problems.&lt;br /&gt;
*Plate cells out in whichever format you require your adipocytes in (i.e. 12 well plates or 15 cm dishes)&lt;br /&gt;
&lt;br /&gt;
==Differentiation of Fibroblasts to Adipocytes==&lt;br /&gt;
*Let cells grow 2-3 days after confluence (typically 8-10 days after a 10X passage)&lt;br /&gt;
*Add Differentiation Media I and incubate 3-4 days.  Cells should shrink after day 1 then start to round up and by *day 3 should begin to accumulate lipid (the media should change color as well)&lt;br /&gt;
*After 3-4 days, add Differentiation Media II and incubate 2-3 days (for a total of 6 days).&lt;br /&gt;
*Change media to Adipocyte media and change every 2-3 days.  Insulin responsiveness (as measured by glucose uptake) increases to a maximum at about 10 days post-differentiation.&lt;br /&gt;
*Good cells should be homogeneous and have &amp;gt;10 fold insulin stimulated glucose uptake.&lt;br /&gt;
*If adipocytes need to be trypsinized for replating or electroporation this is best done before the fourth day after changing to Adipocyte media.  Use 0.25% trypsin.  After that, cells do not trypsinize well.&lt;br /&gt;
&lt;br /&gt;
==Reference==&lt;br /&gt;
PMID 16472699&lt;br /&gt;
[[ Category:Cell Culture ]]&lt;/div&gt;</summary>
		<author><name>Nporitsa</name></author>
	</entry>
	<entry>
		<id>https://bridgeslab.sph.umich.edu/protocols/index.php?title=Paraffin_Embedding_of_Tissue_Samples&amp;diff=812</id>
		<title>Paraffin Embedding of Tissue Samples</title>
		<link rel="alternate" type="text/html" href="https://bridgeslab.sph.umich.edu/protocols/index.php?title=Paraffin_Embedding_of_Tissue_Samples&amp;diff=812"/>
		<updated>2013-12-18T10:51:27Z</updated>

		<summary type="html">&lt;p&gt;Nporitsa: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;br /&gt;
== Protocol ==&lt;br /&gt;
#After harvesting tissue from animal, place into pathology cassette and fix in 4% formaldehyde, 4% paraformaldehyde or 4% formalin O/N&lt;br /&gt;
#After fixation, begin dehydrating the tissue in 70% Ethanol&lt;br /&gt;
#On the day of planned embedding, wash sample with 100% Ethanol 3 times for 30 minutes.&lt;br /&gt;
##While washing in 100% Ethanol, start the paraffin wax machine (Link Building, Room 311)&lt;br /&gt;
#After 100% Ethanol washes, Wash 3 times in Xylenes &lt;br /&gt;
#Wash samples in a beaker filled with wax at 58-60C, 3 times for 15 mins&lt;br /&gt;
#Immediately before embedding, spray wax mold with &amp;quot;Mold Grease&amp;quot; and coat the bottom layer of the mold with wax&lt;br /&gt;
#Take your sample and orient it on top of the base wax as desired&lt;br /&gt;
#Place pathology cassette on top of the mold and fill with wax covering the mold&lt;br /&gt;
#Place mold with sample on &amp;quot;Cold Side&amp;quot; of embedding station &lt;br /&gt;
##Wax will solidify in 10-15 minutes&lt;br /&gt;
#Remove wax embedded sample from the mold (should just slip out) &lt;br /&gt;
#Store at room temperature until prepped to section&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Protocol Edited from: FFPE SOP - MKM and SR for the Williams Lab&lt;br /&gt;
&lt;br /&gt;
1.	Collect tissue&lt;br /&gt;
a.	Immediately place in labeled cassette in 10% buffered formalin&lt;br /&gt;
b.	Place in labeled cassette on dry ice prior to storage at -80C&lt;br /&gt;
&lt;br /&gt;
2.	Fix in 10% buffered formalin&lt;br /&gt;
a.	NOTE: for 3 mm mouse brain sections NEVER exceed 24H in formalin&lt;br /&gt;
&lt;br /&gt;
3.	Tissue processing&lt;br /&gt;
a.	70% EtOH (30 min) → tissues can be kept in 70% Ethanol for long-term storage&lt;br /&gt;
b.	95% EtOH (30 min)&lt;br /&gt;
c.	100% EtOH (30-60 min)&lt;br /&gt;
d.	Xylene (30 min under a fume hood)&lt;br /&gt;
e.	Xylene (30 min under a fume hood)&lt;br /&gt;
f.	Rinse tissues in Paraffin (melting temp of wax, 56 oC for paraplast X-tra)&lt;br /&gt;
g.	Paraffin (melting temp of wax, 56 oC for paraplast X-tra)&lt;br /&gt;
&lt;br /&gt;
*NOTE: Steps 3a to 3e can be done in bulk using plastic histology containers placed on a shaker. In steps 3f to 3g transfer the tissue to a 1.5 ml labeled eppendorf tube and add melted Paraffin → place in a 56 oC heated water bath and floating tube rack.&lt;br /&gt;
&lt;br /&gt;
4.	Embedding&lt;br /&gt;
a.	Spray the stainless steel cassette with ‘base mold release agent’ prior to adding heated wax. &lt;br /&gt;
b.	Pour a small amount (1/3 of the volume) of heated wax into a pre-heated stainless steel cassette and arrange tissue pressing it flat against the bottom with a pre-heated instrument.&lt;br /&gt;
c.	Place the back side of the plastic labeled cassette on top of the stainless steel cassette and fill until wax just covers mesh.&lt;br /&gt;
d.	Chill until paraffin is completely solidified and then remove stainless steel cassette.&lt;br /&gt;
&lt;br /&gt;
Sectioning&lt;br /&gt;
1)	Section 10-15 micron sections from cold blocks of paraffin imbedded tissue with cold blade (pre-chilled in 4 oC).&lt;br /&gt;
2)	Pretreatment of paraffin tissue sections with either of the following&lt;br /&gt;
a.	Leave slides at room temperature for 60 minutes; or &lt;br /&gt;
b.	Heat in dry oven at 55°C for 20 minutes&lt;br /&gt;
Note 1: for adipose, leaving at room temperature prevents disruption of the tissue&lt;br /&gt;
Note 2: For RNA and antigens option (b) is recommended. Option (a) is for highly heat sensitive molecules.&lt;br /&gt;
3)	Immerse slide in xylene for 2 min. (fat) or 10 min. (liver). &lt;br /&gt;
4)	Immerse slide in 100% ethanol for 2 minutes.&lt;br /&gt;
5)	Immerse slide in 95% ethanol for 1 minute.&lt;br /&gt;
6)	Immerse slide in 70% ethanol for 1 minute.&lt;br /&gt;
7)	Immerse slide in 50% ethanol for 1 minute.&lt;br /&gt;
8)	Immerse slide in 1X PBS for 2 minutes.&lt;br /&gt;
9)	Air dry slides for 10-20 min&lt;br /&gt;
&lt;br /&gt;
Protocol Edited from: several online IHC protocols&lt;br /&gt;
&lt;br /&gt;
H&amp;amp;E Staining&lt;br /&gt;
&lt;br /&gt;
Hematoxylin staining&lt;br /&gt;
Incubate slides in Mayer’s Hematoxylin for 20-30 min (fat) or 10 min (liver)&lt;br /&gt;
Rinse in warm H2O (note ‘blueing’ of nuclei)&lt;br /&gt;
&lt;br /&gt;
Eosin staining &lt;br /&gt;
Working solution: &lt;br /&gt;
•	25 mL of 1% Eosin (dissolved in 2 parts of ddH2O and 8 parts of 95% Ethanol)&lt;br /&gt;
•	75 mL of 80% Ethanol&lt;br /&gt;
•	0.5 mL Glacial Acetic Acid&lt;br /&gt;
&lt;br /&gt;
Stain sections for 10 min. in 0.25% Eosin solution&lt;br /&gt;
Rinse slides in ddH2O&lt;br /&gt;
&lt;br /&gt;
Dehydrate slides in &lt;br /&gt;
1)	Immerse slide in 70% ethanol (4 dips) &lt;br /&gt;
2)	Immerse slide in 95% ethanol (2 dips).&lt;br /&gt;
3)	Immerse slide in 100% ethanol (2 dips).&lt;br /&gt;
4)	Immerse slide in xylene for (6 dips)&lt;br /&gt;
&lt;br /&gt;
Mounting&lt;br /&gt;
Apply a drop of mounting medium over the section&lt;br /&gt;
Place the cover slip over in an angle to avoid bubbles&lt;br /&gt;
Store slides at room temperature for 2 h prior to analysis&lt;/div&gt;</summary>
		<author><name>Nporitsa</name></author>
	</entry>
	<entry>
		<id>https://bridgeslab.sph.umich.edu/protocols/index.php?title=Differentiation_of_3T3-L1_Cells&amp;diff=811</id>
		<title>Differentiation of 3T3-L1 Cells</title>
		<link rel="alternate" type="text/html" href="https://bridgeslab.sph.umich.edu/protocols/index.php?title=Differentiation_of_3T3-L1_Cells&amp;diff=811"/>
		<updated>2013-12-18T07:59:17Z</updated>

		<summary type="html">&lt;p&gt;Nporitsa: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
&lt;br /&gt;
==Materials==&lt;br /&gt;
*&#039;&#039;&#039;DMEM&#039;&#039;&#039; (4.5 g/L glucose + L-glutamine – sodium pyruvate; Invitrogen catalog #  11965-092)&lt;br /&gt;
*&#039;&#039;&#039;FBS&#039;&#039;&#039; (we test several batches from several sources for differentiation and insulin stimulated glucose uptake then order large quantities of that particular lot.  Currently we are using Sigma cat# F2442, lot# 072K8403.  Aliquot and store in 50 mL tubes at -20)&lt;br /&gt;
*&#039;&#039;&#039;NCS&#039;&#039;&#039; (currently we are using Biowhittaker Cambrex cat# 14-416F, lot# 01106776; aliquot in 50 mL tubes and store at -20)&lt;br /&gt;
*&#039;&#039;&#039;PSG&#039;&#039;&#039; (100X Invitrogen Cat# 100378-016)&lt;br /&gt;
*&#039;&#039;&#039;Insulin&#039;&#039;&#039; (Sigma I-5523).  Dissolve in 0.01N Hydrochloric acid (28.7μl/50ml) as a 1 mg/ml stock.  Aliquot into 1.5 mL tubes and store at -20&lt;br /&gt;
*&#039;&#039;&#039;Dexamethasone&#039;&#039;&#039; (Sigma D-1756).  Dissolve in ethanol as a 2.5 mM stock (0.049g/50ml).  Aliquot into 1.5 tubes and store at -20.&lt;br /&gt;
*&#039;&#039;&#039;MIX&#039;&#039;&#039; (Sigma I-5879).  Add 2.78g MIX and 0.98g KOH and bring up to 50 mL.   Aliquot into 1.5 mL tubes and store at -20&lt;br /&gt;
*&#039;&#039;&#039;Fibroblast Media&#039;&#039;&#039; (DMEM + 10% NCS + 1X PSG; Sterile filter into new bottle)&lt;br /&gt;
*&#039;&#039;&#039;Adipocyte Media&#039;&#039;&#039; (DMEM + 10 % L1-FBS + 1X PSG; Sterile filter into new bottle)&lt;br /&gt;
*&#039;&#039;&#039;DMI Media&#039;&#039;&#039; (Adipocyte Media + Insulin (1000X dilution), Dexamethasone (10 000X dilution) and MIX (500X dilution); Sterile filter into new bottle after additions&lt;br /&gt;
*&#039;&#039;&#039;Insulin Media&#039;&#039;&#039; (Adipocyte Media + Insulin (1000X dilution); Sterile filter into new bottle after adding insulin)&lt;br /&gt;
&lt;br /&gt;
[[File:3T3-L1_Adipocyte_Differentiation_Schematic.png]]&lt;br /&gt;
&lt;br /&gt;
==Fibroblast Culture==&lt;br /&gt;
*Cells can be grown at 37C + 8% CO2,  and split 10-20X.  Typically healthy fibroblasts will repopulate in 2-3 days after a 10X dilution.&lt;br /&gt;
*Split cells when at about 80% confluence.  Confluence initiates the differentiation program, so if cells reach confluence, you will need to thaw another DMSO stock and start over.  Splitting cells will normally not reverse this&lt;br /&gt;
*When splitting cells, wash cells 2x with sterile PBS (-/-) then add 0.05% trypsin and sit at room temperature for 2-5 min.  Be careful not to over-trypsinize cells&lt;br /&gt;
*Cells can normally be passaged up to about passage # 25 without problems.&lt;br /&gt;
*Plate cells out in whichever format you require your adipocytes in (i.e. 12 well plates or 15 cm dishes)&lt;br /&gt;
&lt;br /&gt;
==Differentiation of Fibroblasts to Adipocytes==&lt;br /&gt;
*Let cells grow 2-3 days after confluence (typically 8-10 days after a 10X passage)&lt;br /&gt;
*Add Differentiation Media I and incubate 3-4 days.  Cells should shrink after day 1 then start to round up and by *day 3 should begin to accumulate lipid (the media should change color as well)&lt;br /&gt;
*After 3-4 days, add Differentiation Media II and incubate 2-3 days (for a total of 6 days).&lt;br /&gt;
*Change media to Adipocyte media and change every 2-3 days.  Insulin responsiveness (as measured by glucose uptake) increases to a maximum at about 10 days post-differentiation.&lt;br /&gt;
*Good cells should be homogeneous and have &amp;gt;10 fold insulin stimulated glucose uptake.&lt;br /&gt;
*If adipocytes need to be trypsinized for replating or electroporation this is best done before the fourth day after changing to Adipocyte media.  Use 0.25% trypsin.  After that, cells do not trypsinize well.&lt;br /&gt;
&lt;br /&gt;
==Reference==&lt;br /&gt;
PMID 16472699&lt;br /&gt;
[[ Category:Cell Culture ]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Protocol: Adipogenic Differentiation of Mouse Embryonic Fibroblasts (MEFs)&lt;br /&gt;
Strains: Wild type (Tsc2 +/+) and Tsc2 -/- (p53−/−) MEFs &lt;br /&gt;
Source: DJ Kwiatkowski (Brigham and Women&#039;s Hospital, Boston, MA)&lt;br /&gt;
Papers: &lt;br /&gt;
•	Kwiatkowski DJ, Zhang H, Bandura JL, Heiberger KM, Glogauer M, et al. (2002) A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in TSC1 null cells. Hum Mol Genet 11: 525–534. &lt;br /&gt;
•	Zhang H, Cicchetti G, Onda H, Koon HB, Asrican K, et al. (2003) Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR. J Clin Invest 112: 1223–1233.&lt;br /&gt;
&lt;br /&gt;
Materials&lt;br /&gt;
•	DMEM (4.5 g/L glucose + L-glutamine – sodium pyruvate; Invitrogen catalog # 11965-092)&lt;br /&gt;
•	FBS (we test several batches from several sources for differentiation and insulin stimulated glucose uptake then order large quantities of that particular lot. Currently we are using Sigma cat# F2442, lot# 072K8403. Aliquot and store in 50 mL tubes at -20)&lt;br /&gt;
•	NCS (currently we are using Biowhittaker Cambrex cat# 14-416F, lot# 01106776; aliquot in 50 mL tubes and store at -20)&lt;br /&gt;
•	Penicillin/Streptomycin (100X Invitrogen Cat# 100378-016)&lt;br /&gt;
•	Insulin (Sigma I-5523). Dissolve in 0.01N Hydrochloric acid (28.7μl/50ml) as a 1 mg/ml stock. Aliquot into 1.5 mL tubes and store at -20&lt;br /&gt;
•	Dexamethasone (Sigma D-1756). Dissolve in ethanol as a 2.5 mM stock (0.049g/50ml). Aliquot into 1.5 tubes and store at -20.&lt;br /&gt;
•	MIX (Sigma I-5879). Add 2.78g MIX and 0.98g KOH and bring up to 50 mL. Aliquot into 1.5 mL tubes and store at -20&lt;br /&gt;
•	Fibroblast Media (DMEM + 10% NCS + 1X PSG; Sterile filter into new bottle)&lt;br /&gt;
•	Adipocyte Media (DMEM + 10 % L1-FBS + 1X PSG; Sterile filter into new bottle)&lt;br /&gt;
•	DMI Media (Adipocyte Media + Insulin (1000X dilution), Dexamethasone (10 000X dilution) and MIX (500X dilution); Sterile filter into new bottle after additions&lt;br /&gt;
•	Insulin Media (Adipocyte Media + Insulin; Sterile filter into new bottle after adding insulin)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Induction of MEF differentiation: &lt;br /&gt;
1.	Seed MEFs at 100% confluence in 12-well plates and grow for 2 days (D0).&lt;br /&gt;
2.	On day 0 (D0) treat MEFs with differentiation-inducing media containing insulin (830 nM), dexamethasone (1 µM), and 3-isobutyl-1-methylxanthine (IBMX, 0.5 mM).&lt;br /&gt;
3.	At 48 hours, replace the media with the maintenance DMEM medium containing 10% FBS and insulin (830-nM), followed by a replenishment of the media every 2 days until the end of adipogenic differentiation (prior to cells lifting off).&lt;br /&gt;
•	Note1 Cells should shrink after day 1, and then start to round up. By *day 3 cells should begin to accumulate lipid (the media should change color as well)&lt;br /&gt;
4.	Protein lysate and RNA extraction is taken at day 4 (D3).  &lt;br /&gt;
•	Note2: In the 12-well plate, Tsc2-/- MEFs started to be detached from the plate on D3, and consequently lysates were taken at that point to ensure adequate sample collection.&lt;br /&gt;
•	Note3: A 6-well plate can also be used to increase surface area and protein/RNA content from each treatment. Seeding density of 90% followed by 2 days of growth prior to adipogenic differentiation may increase adherence and maintenance of Tsc2-/- MEFs.&lt;/div&gt;</summary>
		<author><name>Nporitsa</name></author>
	</entry>
</feed>